InnoCare Pharma (SHA:688428, HKG:9969) said China's drug regulator accepted the new drug application for orelabrutinib for treating primary immune thrombocytopenia (ITP), according to a Friday filing with the Shanghai bourse.
Shares of the drugmaker rose 3% in recent trade on the Hong Kong bourse.
Solar Industries India (NSE:SOLARINDS, BOM:532725) has secured export orders worth 10.8 billion Indian rupees from undisclosed international clients, according to a Friday filing with the Indian stock exchanges.The contract is for the supply of defense products over three years.The company's shares were down nearly 1% in recent trade.
Superloop (ASX:SLC) completed the acquisition of Lynham Networks, the parent company of Lightning Broadband, for AU$165 million in cash consideration, according to a Friday Australian bourse filing.The acquisition was executed on Feb. 18.The cash consideration is subject to final completion adjustments in accordance with the share purchase agreement, the filing said. The acquisition was funded from existing cash and Superloop's debt facilities.The company's shares fell past 3% in recent trading on Friday.
Shanghai Fosun Pharmaceutical (SHA:600196) subsidiary Yaoyou Pharmaceutical signed an exclusive license agreement with Chongqing Genrix Biopharmaceutical (SHA:688443) for bispecific antibody GR1803.The deal includes up to 600 million yuan in upfront, milestone and technology transfer payments, plus tiered royalties, according to a Friday filing with the Shanghai bourse.Yaoyou Pharmaceutical will act as marketing authorization holder for mainland China, Hong Kong, Macau and Taiwan.GR1803 targets multiple myeloma and lupus.Shares of the pharmaceutical company were up 2% in recent trade.